Boundless Bio (BOLD) Other Operating Expenses (2024 - 2026)
Boundless Bio (BOLD) posted quarterly Other Operating Expenses of -$493000.0 for Q1 2026, up 32.09% year-over-year from -$373220.0 in Q1 2025, and up 6.45% quarter-over-quarter from -$527000.0 in Q4 2025.
Boundless Bio (BOLD) Other Operating Expenses (2024 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Other Operating Expenses for 3 consecutive years, with -$493000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 32.09% year-over-year to -$493000.0; the TTM figure through Mar 2026 stood at -$2.2 million (up 18.87% YoY), while the FY2025 annual figure was -$2.4 million, down 3.43% from the prior year.
- Other Operating Expenses rose to -$493000.0 in Q1 2026 per BOLD's latest filing, from -$527000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$372000.0 in Q1 2024 and bottomed at -$726000.0 in Q1 2025.
- Historically, Other Operating Expenses has averaged -$582111.1 across 3 years, with a median of -$595000.0 in 2024.
- Annual changes were most pronounced in 2025 — Other Operating Expenses slumped 95.16% — and 2026, when it surged 32.09%.
- Boundless Bio's Other Operating Expenses stood at -$680000.0 in 2024, then increased by 22.5% to -$527000.0 in 2025, then advanced by 6.45% to -$493000.0 in 2026.
- Business Quant data shows BOLD's Other Operating Expenses at -$493000.0 in Q1 2026, -$527000.0 in Q4 2025, and -$542000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Boundless Bio | 66.79 Mn | 66.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -493,000.00 |
| Dec 31, 2025 | -527,000.00 |
| Sep 30, 2025 | -542,000.00 |
| Jun 30, 2025 | -618,000.00 |
| Mar 31, 2025 | -726,000.00 |
| Dec 31, 2024 | -680,000.00 |
| Sep 30, 2024 | -686,000.00 |
| Jun 30, 2024 | -595,000.00 |
| Mar 31, 2024 | -372,000.00 |